“Skin manifestations associated with Glucagon-Like Peptide-1 (GLP-1) receptor agonist use for weight loss: A cross-sectional analysis” (2026) Journal of Pakistan Association of Dermatologists, 36(1), pp. 3–9. doi:10.66344/jpad.v36i1.3221.